Menu
Eng Slo
Kontaktirajte nas
Novica
September 16, 2026

Slovenska ministrska delegacija obiskala Cosylab, da se podrobno seznani o projektu AMID

Leon Korošec underlined how important it is for Slovenia that its deep-tech companies compete successfully at the cutting edge of deep-tech and medical solutions

Cosylab je 14. septembra 2026 gostil predstavnike dveh slovenskih ministrstev, ki so se pobliže seznanili s projektom AMID in ekipo, ki ga razvija. AMID je Cosylabov projekt v okviru evropske pobude IPCEI Tech4Cure, namenjene razvoju inovativnih zdravstvenih tehnologij.   

Z Ministrstva za gospodarstvo, delo in šport so se obiska udeležili Leon Korošec, državni sekretar za gospodarstvo; Nena Dokuzov, nacionalna koordinatorica za IPCEI na področju zdravja; Tjaša Rotar Kokalj, državna sekretarka, odgovorna za operativne prijave projektov IPCEI; Matej Novak, skrbnik pogodbe za projekt AMID; in Matej Skočir, vršilec dolžnosti direktorja Direktorata za internacionalizacijo. Ministrstvo za lokalno samoupravo, kohezijo in regionalni razvoj je zastopal Rok Šimenc, državni sekretar, odgovoren za kohezijsko politiko. 

Dr. Mark Pleško, izvršni direktor Cosylaba, dr. Kristjan Anderle, znanstveni vodja projekta, in Igor Verstovšek, vodja programa umetne inteligence v Cosylabu so za obiskovalce priprvili posebno predstavitev projekta. Delegacijo so popeljali skozi temeljne tehnologije, na katerih temelji AMID, ter skozi Cosylabove kompetence na področju radioterapije in umetne inteligence (AI). Hkrati so pokazali, kako se obe disciplini lahko povežeta, da postane radiološko zdravljenje raka natančnejše, bolj prilagodljivo in širše dostopno. 

Leon Korošec je poudaril, kako pomembno je za Slovenijo, da njena visokotehnološka podjetja uspešno tekmujejo na najzahtevnejših področjih naprednih in medicinskih tehnologij ter se kosajo z najmočnejšimi svetovnimi igralci. Nena Dokuzov je izpostavila, da je Cosylab s svojim sodelovanjem okrepil zaupanje v to, da lahko slovenska podjetja tudi v drugih projektih IPCEI nastopajo kot neposredni partnerji. 

Sledila je živahna razprava, ki se je začela pri tehničnih temeljih projekta in se nadaljevala k temu, kaj pomeni AMID za rakave bolnike in za položaj Slovenije na področju naprednih medicinskih tehnologij. 

Veseli nas, da smo lahko gostili obiskovalce, in se veselimo nadaljnjega sodelovanja z našimi partnerji ter z institucijami, ki podpirajo evropske ambicije na področju zdravstvenih tehnologij.  

Cosylab welcomed a delegation of representatives from two Slovenian ministries, who came to learn in detail about AMID
Dr Kristjan Anderle, chief scientific lead on the project, walked the visitors through the core radiotherapy technologies behind AMID.
AMID's aim is to make radiotherapy treatment more precise, more adaptive, and more widely accessible.
Cosylab welcomed a delegation of representatives from two Slovenian ministries, who came to learn in detail about AMID
Dr Kristjan Anderle, chief scientific lead on the project, walked the visitors through the core radiotherapy technologies behind AMID.
AMID's aim is to make radiotherapy treatment more precise, more adaptive, and more widely accessible.
Cosylab welcomed a delegation of representatives from two Slovenian ministries, who came to learn in detail about AMID
Dr Kristjan Anderle, chief scientific lead on the project, walked the visitors through the core radiotherapy technologies behind AMID.
AMID's aim is to make radiotherapy treatment more precise, more adaptive, and more widely accessible.
Oktober 02, 2026
Novica
AMID na ASTRO 2026 v Bostonu!
Avgust 11, 2026
Novica
AMID — razvoj napredne radioterapije s podporo Slovenije in EU
AMID je evropski raziskovalni in inovacijski projekt, osredotočen na programsko podprte pristope za obdelavo medicinskih slik in načrtovanje radioterapije.
Something went wrong.
Something went right.
Hvala!
Zahvaljujemo se vam za poslano sporočilo in vam bomo odgovorili v najkrajšem času!

We use cookies to enhance your browsing experience, display personalized ads or content, and analyze site traffic. By clicking on Allow all and close you agree to our use of cookies.

Cookie settings

Your Privacy

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information may relate to you, your preferences, your device, or be used to ensure that the website functions as you expect. The information usually does not directly identify you, but it can provide you with a more personalized web experience. You can choose to reject certain types of cookies. Click on the different category headings to learn more and change the default settings. Blocking certain types of cookies may impact your experience of the website and the services we are able to offer.

Strictly necessary cookies
These cookies are essential for the functioning of the website and cannot be switched off in our systems. They are usually set only in response to actions you take that amount to a request for services, such as setting your privacy preferences, logging in, or filling out forms. You can set your browser to block these cookies or alert you about them, but some parts of the website will not function properly as a result.
Always active
Performance cookies
With these cookies, we count visits and traffic sources to measure and improve the performance of our website. They help us identify which pages are the most and least popular and observe how visitors navigate through the site. The data collected by these cookies is aggregated and anonymous. If you refuse the use of these cookies, we will not know when you have visited our website.
Advertising cookies
These cookies are set by our advertising partners. Partner advertising companies may use them to build a profile of your interests, which is then used to display relevant ads on other websites. They work by uniquely identifying your browser and device. If you refuse the use of these cookies, you will not receive our targeted online advertising.